about
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical reviewCardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trialsThe impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancerBiomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitorsPertuzumab in HER2-positive early breast cancer: current use and perspectives
P50
Q47169337-C7831834-E551-4611-AEF8-DBC88F926F0DQ64326294-28BD9937-A4AF-43CA-86FF-2B1FB26E7289Q89807860-6B7657A1-169C-43B4-BA46-0B79BD3950DBQ90295528-9954124A-B6DD-4B1F-B4E4-F40899CCCDF8Q90437273-D64B6AC0-20C4-4664-A90D-135291D7BABBQ92143284-502ECA28-F677-44FC-804E-B721ABD1073AQ92782149-D12E5639-9B06-468D-A5D5-B0E00D1E494F
P50
description
researcher
@en
wetenschapper
@nl
name
Daniel Eiger
@en
Daniel Eiger
@nl
type
label
Daniel Eiger
@en
Daniel Eiger
@nl
prefLabel
Daniel Eiger
@en
Daniel Eiger
@nl
P31
P496
0000-0002-9879-6048